Comparative Data Sample Clauses

Comparative Data. I acknowledge that I have received with this Agreement a list for my facility of the job titles of those affected by the current layoff or restructuring to date and the ages of those affected and not affected in those job classifications as set forth in Exhibit B. The class, unit, or group of individuals considered by this severance program impacts certain members of the Company’s Named Executive Officers (“NEOs”). Only the employees selected for layoff are eligible for or offered separation benefits in exchange for signing a waiver and release. To actually receive the consideration set forth in Section 2, the individuals, including Executive, must timely sign and not revoke this Agreement.
AutoNDA by SimpleDocs
Comparative Data. Plateletworks vs PRP Aggregometry N (Xxxxxxx)r Xxxxxxxx Rho ADP 225 0.83* 0.68* *P < 0.001 two-sided test of positive association significant Comparative Data: Liquid Collagen vs Lyophilized Collagen N (Xxxxxxx)r Xxxxxxxx Rho Collagen 154 0.89* 0.88* *P < 0.001 two-sided test of positive association significant Note: Thrombocytopenic samples may be tested using the Plateletworks assay. As this system utilizes electrical impedance cell counting principles (i.e., Ichor II Analyzer), instrument platelet counts > 10 x 103/mL can be accurately obtained. Agonist platelet counts can be measured in samples meeting the limits of aggregation detection (> 27 x 103/mL). Although EDTA-induced thrombocytopenic samples may be tested using the Plateletworks assay, no actual testing was performed on this sample type. Precision Precision of the Plateletworks assay was determined in two ways. First, a sample from a single healthy volunteer was tested on each of ten days with the agonist. (Although the samples were drawn from the same individual, some differences are to be expected due to diurnal physiological variation.) The coefficients of variation was 5.1% for ADP and 5.9% for Collagen. Additionally, 10 sample aliquots from a single healthy volunteer were tested during a 20 minute interval with the agonist. The coefficients of variation was 4.1% for ADP and 4.9% for Collagen. This data supports the reproducibility of the Plateletworks assay. Thus, duplicate testing on a routine basis is not required. Nonetheless, any questionable test result should be repeated, and performed in duplicate. BIBLIOGRAPHY Bibliografia/Bibliographie/Bibliografia/Literatur
Comparative Data. For comparative purposes, the amounts and rates set forth in budgets shall be shown as follows:

Related to Comparative Data

  • Accounting Information Without limiting the generality of Section 7.01 but subject to Section 7.01(b):

  • Quantitative Analysis Quantitative analysts develop and apply financial models designed to enable equity portfolio managers and fundamental analysts to screen potential and current investments, assess relative risk and enhance performance relative to benchmarks and peers. To the extent that such services are to be provided with respect to any Account which is a registered investment company, Categories 3, 4 and 5 above shall be treated as “investment advisory services” for purposes of Section 5(b) of the Agreement.”

  • Financial Information Upon written request the Company agrees to send or make available the following reports to the Buyer until the Buyer transfers, assigns, or sells all of the Securities: (i) within ten (10) days after the filing with the SEC, a copy of its Annual Report on Form 10-K its Quarterly Reports on Form 10-Q and any Current Reports on Form 8-K; (ii) within one (1) day after release, copies of all press releases issued by the Company or any of its Subsidiaries; and (iii) contemporaneously with the making available or giving to the shareholders of the Company, copies of any notices or other information the Company makes available or gives to such shareholders.

  • Basic Financial Information The Company will furnish the following reports to each Holder:

  • Financial Information, etc The Administrative Agent shall have received:

  • Cost Basis Information (a) In the event of a cash exercise, the Company hereby instructs the Warrant Agent to record cost basis for newly issued shares in a manner to be subsequently communicated by the Company in writing to the Warrant Agent.

  • Annual Information The Company will deliver to the Holder as soon as available and in any event within 90 days after the end of each fiscal year of the Company, one copy of an audited consolidated balance sheet of the Company and its subsidiaries as at the end of such year, and audited consolidated statements of income, retained earnings and cash flow of the Company and its subsidiaries for such year; setting forth in each case in comparative form the figures for the corresponding periods in the previous fiscal year; all prepared in accordance with GAAP, and which audited financial statements shall be accompanied by an opinion thereon of the independent certified public accountants regularly retained by the Company, or any other firm of independent certified public accountants of recognized national standing selected by the Company; provided, however, that the Company shall have no obligation to deliver such annual information under this Section 13.2 to the extent it is publicly available; and provided further, that if such information contains material non-public information, the Company shall so notify the Holder prior to delivery thereof and the Holder shall have the right to refuse delivery of such information.

  • Royalty Statements The Licensees shall provide Shengqu with a statement within ten (10) Business Days of the end of each calendar month during the Term of this Agreement.

Time is Money Join Law Insider Premium to draft better contracts faster.